T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis.
暂无分享,去创建一个
Marco Rovaris | Massimo Corbo | Mario Clerici | Paola Tortorella | Christian Lunetta | Domenico Caputo | M. Rovaris | M. Clerici | D. Caputo | M. Saresella | I. Marventano | F. Piancone | M. Corbo | P. Tortorella | A. Gatti | C. Lunetta | Marina Saresella | Federica Piancone | Ivana Marventano | Andrea Gatti | Andrea Gatti
[1] M. Clerici,et al. Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis. , 1998, Journal of immunology.
[2] F. Annunziato,et al. The transient nature of the Th17 phenotype , 2010, European journal of immunology.
[3] M. Schwartz,et al. Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: A dialogue with microglia , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. Newcombe,et al. Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration , 2012, The Journal of experimental medicine.
[5] Andreas Radbruch,et al. Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. , 2010, Immunity.
[6] M. Michalopoulou,et al. Interleukin‐17 and interleukin‐23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation? , 2010, Acta neurologica Scandinavica.
[7] L. Glimcher,et al. T-bet in disease , 2011, Nature Immunology.
[8] M. Filippi,et al. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease , 2001, Journal of Neuroimmunology.
[9] M. Clerici,et al. Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis , 2009, Multiple sclerosis.
[10] S. Dhib-jalbut,et al. Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis , 2002, Neurology.
[11] W. Brück,et al. BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? , 2002, Brain : a journal of neurology.
[12] W. Leonard,et al. Cytokine mediators of Th17 function , 2009, European Journal of Immunology.
[13] Massimo Filippi,et al. Towards a neuroimaging biomarker for amyotrophic lateral sclerosis , 2011, The Lancet Neurology.
[14] D. Littman,et al. Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.
[15] R. Flavell,et al. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. , 2009, Current opinion in pharmacology.
[16] H. Neumann,et al. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. , 2010, Brain : a journal of neurology.
[17] B. Trapp,et al. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis , 2011, Progress in Neurobiology.
[18] Hans Lassmann,et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.
[19] Hans Lassmann,et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains , 2009, Brain : a journal of neurology.
[20] P. Sørensen,et al. Demyelination versus remyelination in progressive multiple sclerosis. , 2010, Brain : a journal of neurology.
[21] R. Gold,et al. Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination , 2011, Acta Neuropathologica.
[22] M. Strong,et al. The Pathobiology of Amyotrophic Lateral Sclerosis: A Proteinopathy? , 2005, Journal of neuropathology and experimental neurology.
[23] P. Mcgeer,et al. Inflammatory processes in amyotrophic lateral sclerosis , 2002, Muscle & nerve.
[24] S. Sawcer,et al. Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72 , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[25] Nathalie Arbour,et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.
[26] F. Sallusto,et al. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells , 2007, Nature Immunology.
[27] K. Kawabe,et al. Interleukin‐17 and ‐23 levels in amyotrophic lateral sclerosis , 2011, Acta neurologica Scandinavica.
[28] J. Niland,et al. Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases , 1998, Journal of the Neurological Sciences.
[29] T. Holmøy,et al. T cells in amyotrophic lateral sclerosis , 2008, European journal of neurology.
[30] F. Jadidi-Niaragh,et al. Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis , 2011, Scandinavian journal of immunology.
[31] M. Tuszynski,et al. Potential therapeutic uses of BDNF in neurological and psychiatric disorders , 2011, Nature Reviews Drug Discovery.
[32] M. Rovaris,et al. Costimulatory Pathways in Multiple Sclerosis: Distinctive Expression of PD-1 and PD-L1 in Patients with Different Patterns of Disease1 , 2009, The Journal of Immunology.
[33] Shimon Sakaguchi,et al. Natural regulatory T cells: mechanisms of suppression. , 2007, Trends in molecular medicine.
[34] James Sayre,et al. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients , 2010, Journal of Neuroinflammation.
[35] G. Guazzi,et al. IL-6 detection in multiple sclerosis brain , 1997, Journal of the Neurological Sciences.
[36] M. Filippi,et al. Programmed cell death of myelin basic protein-specific T lymphocytes is reduced in patients with acute multiple sclerosis , 2005, Journal of Neuroimmunology.
[37] Tony Wyss-Coray,et al. Inflammation in Neurodegenerative Disease—A Double-Edged Sword , 2002, Neuron.
[38] M. Clerici,et al. CD4+CD25+FoxP3+PD1— regulatory T cells in acute and stable relapsing‐remitting multiple sclerosis and their modulation by therapy , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] F. Shi,et al. Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen1 , 2005, The Journal of Immunology.
[40] F. Barkhof,et al. Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)‐enhanced MRI to demonstrate diffuse inflammation in the normal‐appearing white matter (NAWM) of multiple sclerosis (MS) patients: An exploratory study , 2009, Journal of magnetic resonance imaging : JMRI.
[41] M. Etemadifar,et al. Multiple sclerosis and amyotrophic lateral sclerosis: is there a link? , 2012, Multiple sclerosis.